Flow cytometry analysis was performed using anti-SSEA1-eFluor 660 (eBioscience 50-8813-42, 1:20), anti-CD44-FITC (IM7) (eBioscience, 11-0441-81, 0.5 mg per test) and anti-CD24-VioBlue (clone: 32D12) (Miltenyi biotech, 130-099-150, 1:11). For tumor-derived samples, anti-mouse MHC Class I H2-Kd (eBioscience 17-5957-82, 1:200) followed by PerCP-Cy5.5-conjugated streptavidin (eBioscience 45-4317-80, 1:200) was used to exclude host cells. Cells were incubated with antibodies at a concentration of 1 × 106 cells/100 μL in sort buffer (15 mM HEPES buffer [Sigma H3375], 1% Bovine Serum Albumin [Sigma A9647], 2 mM EDTA [VWR 20302.260], 100 U/mL DNase I (NEB M0303), 100 U/mL penicillin and 100 μg/mL streptomycin [Thermo Fisher 15140122] in PBS) for 45 min on ice, washed 3 times with sort buffer and analyzed using LSR Fortessa (BD Biosciences) or sorted using FACSAria II (BD Biosciences). FACSDiva and FlowJo software were used to acquire and analyzed data, respectively. Gating strategy used for tumor analysis is shown in Supplementary Fig. 1 .
Anti cd44 fitc im7
Manufactured by Thermo Fisher Scientific
Anti-CD44-FITC (IM7) is a fluorescently-labeled antibody that targets the CD44 cell surface antigen. It is designed for use in flow cytometry applications.
Automatically generated - may contain errors
Lab products found in correlation
Penicillin, by Thermo Fisher Scientific (4 mentions)
Streptomycin, by Thermo Fisher Scientific (4 mentions)
Dnase 1, by New England Biolabs (2 mentions)
Anti ssea1 efluor 660, by Thermo Fisher Scientific (2 mentions)
Anti cd24 vioblue clone 32d12, by Miltenyi Biotec (2 mentions)
Percp cy5.5 conjugated streptavidin, by Thermo Fisher Scientific (2 mentions)
Facsdiva, by FlowJo (2 mentions)
Bovine serum albumin (bsa), by Merck Group (2 mentions)
Lsrfortessa, by BD (2 mentions)
Facsaria 2, by BD (2 mentions)
2 protocols using anti cd44 fitc im7
1
Flow Cytometry Analysis of SSEA1, CD44, and CD24
2
Flow Cytometry Analysis of SSEA1, CD44, and CD24
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Flow cytometry analysis was performed using anti-SSEA1-eFluor 660 (eBioscience 50-8813-42, 1:20), anti-CD44-FITC (IM7) (eBioscience, 11-0441-81, 0.5 mg per test) and anti-CD24-VioBlue (clone: 32D12) (Miltenyi biotech, 130-099-150, 1:11). For tumor-derived samples, anti-mouse MHC Class I H2-Kd (eBioscience 17-5957-82, 1:200) followed by PerCP-Cy5.5-conjugated streptavidin (eBioscience 45-4317-80, 1:200) was used to exclude host cells. Cells were incubated with antibodies at a concentration of 1 × 106 cells/100 μL in sort buffer (15 mM HEPES buffer [Sigma H3375], 1% Bovine Serum Albumin [Sigma A9647], 2 mM EDTA [VWR 20302.260], 100 U/mL DNase I (NEB M0303), 100 U/mL penicillin and 100 μg/mL streptomycin [Thermo Fisher 15140122] in PBS) for 45 min on ice, washed 3 times with sort buffer and analyzed using LSR Fortessa (BD Biosciences) or sorted using FACSAria II (BD Biosciences). FACSDiva and FlowJo software were used to acquire and analyzed data, respectively. Gating strategy used for tumor analysis is shown in Supplementary Fig. 1 .
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!